Fundraising Fox

Lyric Pharmaceuticals

South San Francisco, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

DW
David WurtmanExecutive
MS
M. Scott HarrisExecutive

Board

JH
Jason HongBoard director
CC
Casey CunninghamBoard director
NO
Niall O'DonnellinBoard directorManaging Director at RiverVest Venture Partners
SZ
Sanford ZweifachBoard director

Investors · 1

RiverVest Venture PartnersreportedSt. Louis · $500K – $3Mvia Niall O'Donnell · board

Reported raises · per SEC filings

Form D private placements

$26.8M disclosed across 1 round · 2015

▶$26.8MraisedApr 2017 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David WurtmanExecutive Officer, Director
  • Sanford ZweifachDirector
  • Jason HongDirector
  • Casey CunninghamDirector
  • M. Scott HarrisExecutive Officer
  • Niall O'DonnellDirector
Offering amount
$33.9M
Amount sold
$26.8M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Lyric Pharmaceuticals's investors?
Lyric Pharmaceuticals's investors include RiverVest Venture Partners.
How much funding has Lyric Pharmaceuticals raised?
Lyric Pharmaceuticals has disclosed $26.8M raised across 1 round.
Where is Lyric Pharmaceuticals headquartered?
Lyric Pharmaceuticals is headquartered in South San Francisco, US.